Search results
In review of Lilly Alzheimer’s drug, FDA staff focus on safety, patient selection
BioPharma Dive via Yahoo Finance· 10 hours agoThe agency is seeking input from an advisory panel on whether donanemab is effective across...
Eli Lilly Alzheimer’s drug should come with safety warning
Seeking Alpha· 8 hours agoThe US FDA has suggested a safety warning for Eli Lilly's (LLY) Alzheimer's therapy, donanemab,...
FDA Advisors Recommend Against Using MDMA for PTSD Treatment
Time via Yahoo News· 1 day agoThe drug has been shown to trigger feelings of euphoria and closeness, and can distort time and...
Brain fluid probed by ultrasound using squishy cubes
Nature· 2 days agoInjectable hydrogels gauge changes in the brain.
FDA Panel Rejects MDMA Drug for PTSD
Medscape· 2 days agoA US Food and Drug Administration (FDA) expert panel has found that the benefits of the psychedelic midomafetamine (MDMA) in combination with psychological intervention for ...
Entire tech stack rethink needed to solve AI energy crisis
The Register· 1 day agoHAI's goal is to keep people...design, but human-centered AI can also be taken as a nod to the...
High Confidence AD Drug Donanemab Will Get FDA Panel Nod
Medscape· 3 days agoThe Peripheral and Central Nervous System Drugs Advisory Committee of the US Food and Drug...
Traumatic brain injury affects 1 in 8 older Americans
UPI· 6 days agoMedicare data shows that about 13% of seniors suffered a severe concussion during an average...
Up 43% to 133%, Is It Too Late to Buy These 3 Stocks?
Motley Fool via Yahoo Finance· 1 day agoA high-quality investment could continue strong growth and even outperform for years to come. The...
FDA panel rejects first MDMA treatment amid deep concerns about flawed trials
NBC News via Yahoo News· 2 days agoA Food and Drug Administration advisory panel on Tuesday declined to recommend the approval of MDMA,...